ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.

Elizabeth A Mittendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.